CA
RVMDW icon

CoreCap Advisors’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

CoreCap Advisors’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$14 – 2961
2024
Q3 		$14 Hold
100
– – ﹤0.01% 2610
2024
Q2 		$10 Hold
100
– – ﹤0.01% 1589
2024
Q1 		$18 Buy
+100
New +$20 ﹤0.01% 2499

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

CoreCap Advisors's RVMDW Position: Q4 2024 in Review

CoreCap Advisors sold out of Revolution Medicines Inc Warrant (RVMDW) in Q4 2024, closing a stake of 100 shares — an estimated $14 sold.

CoreCap Advisors first reported a position in RVMDW in Q1 2024 and held it in 3 quarters. The position peaked at $18 in Q1 2024. 24 funds tracked by Wall St. Rank hold RVMDW as of Q4 2024.

  • CoreCap Advisors reported no remaining Revolution Medicines Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • CoreCap Advisors sold 100 Revolution Medicines Inc Warrant shares in Q4 2024, an estimated $14.
  • CoreCap Advisors first reported a position in Revolution Medicines Inc Warrant in Q1 2024 and held it in 3 quarters.
  • CoreCap Advisors's Revolution Medicines Inc Warrant position peaked at $18 in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q4 2024.

Based on CoreCap Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.